Rep. Terri A. Sewell Sells GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares

Representative Terri A. Sewell (Democratic-Alabama) recently sold shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC). In a filing disclosed on April 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in GE HealthCare Technologies stock on March 25th.

Representative Terri A. Sewell also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of Tapestry (NYSE:TPR) on 3/25/2026.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $71.38 on Thursday. GE HealthCare Technologies Inc. has a twelve month low of $64.28 and a twelve month high of $89.77. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $32.57 billion, a price-to-earnings ratio of 15.65, a PEG ratio of 1.59 and a beta of 1.17. The firm has a 50-day moving average of $75.05 and a two-hundred day moving average of $77.88.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same period in the prior year, the company earned $1.45 EPS. GE HealthCare Technologies’s revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 5 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

Hedge Funds Weigh In On GE HealthCare Technologies

Several institutional investors and hedge funds have recently bought and sold shares of the business. Patriot Financial Group Insurance Agency LLC purchased a new position in GE HealthCare Technologies during the 1st quarter valued at about $268,000. Skylands Capital LLC grew its stake in GE HealthCare Technologies by 28.3% during the 1st quarter. Skylands Capital LLC now owns 161,090 shares of the company’s stock valued at $11,466,000 after acquiring an additional 35,550 shares in the last quarter. Janney Montgomery Scott LLC grew its stake in GE HealthCare Technologies by 5.9% during the 1st quarter. Janney Montgomery Scott LLC now owns 58,238 shares of the company’s stock valued at $4,145,000 after acquiring an additional 3,227 shares in the last quarter. Diamant Asset Management Inc. grew its stake in GE HealthCare Technologies by 7,634.7% during the 1st quarter. Diamant Asset Management Inc. now owns 797,216 shares of the company’s stock valued at $56,746,000 after acquiring an additional 786,909 shares in the last quarter. Finally, Beaumont Asset Management L.L.C. grew its stake in GE HealthCare Technologies by 13.9% during the 1st quarter. Beaumont Asset Management L.L.C. now owns 8,149 shares of the company’s stock valued at $580,000 after acquiring an additional 995 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of research analyst reports. Morgan Stanley upped their price target on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Wednesday, February 4th. Evercore upped their price target on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Citigroup cut their price target on shares of GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a report on Wednesday, March 11th. Finally, The Goldman Sachs Group cut their price target on shares of GE HealthCare Technologies from $97.00 to $81.00 and set a “buy” rating for the company in a report on Thursday, April 9th. Eight research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Hold” and a consensus target price of $89.77.

About Representative Sewell

Terri Sewell (Democratic Party) is a member of the U.S. House, representing Alabama’s 7th Congressional District. She assumed office on January 3, 2011. Her current term ends on January 3, 2027.

Sewell (Democratic Party) is running for re-election to the U.S. House to represent Alabama’s 7th Congressional District. She declared candidacy for the 2026 election.

Below is an abbreviated outline of Sewell’s academic, professional, and political career:

2011-Present: U.S. Representative from Alabama’s 7th Congressional District
1992: Graduated from Harvard University with J.D.
1988: Graduated from Oxford University with M.A.
1986: Graduated from Princeton University with B.A.
Prior to serving in Congress, Sewell was a partner in the Birmingham law office of Maynard, Cooper & Gale, P.C., where she focused on securities and public finance law.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.